IgG4-related hepatobiliary diseases (IgG4-HBD) are part of a systemic fibroinflammatory condition, termed IgG4-related disease. IgG4-HBD includes IgG4-related sclerosing cholangitis (IgG4-SC) and IgG4 ...

Healio spoke with Marlyn Mayo, MD, about increased research focused on symptoms of primary sclerosing cholangitis presented at The Liver Meeting, as well as treatments being ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Statin therapy decreased the risk for developing acute cholangitis among patients with primary ...

The new therapy strategy for primary sclerosing cholangitis, a liver disease that at present still cannot be cured with medication, shows initial measureable success with the nor-ursodeoxycholic acid ...

Although a colonoscopy for the evaluation of IBD and the surveillance of colitis-associated neoplasia should be performed at the time of the diagnosis of primary sclerosing cholangitis (PSC), the ...

The clinical research and development program will be conducted in collaboration with the Stravitz–Sanyal Institute for Liver Disease and Metabolic Health Virginia Commonwealth University. TEL AVIV, ...

New Peer-Reviewed Publication Highlights Phase 2 SPRING Trial Data Supporting the Disease Modifying Potential of Nebokitugin PSC and Supports ...